Leonard L. Mazur - Oct 10, 2023 Form 4 Insider Report for Citius Pharmaceuticals, Inc. (CTXR)

Role
Chief Executive Officer, Director, 10%+ Owner
Signature
/s/ Alexander M. Donaldson, by power of attorney
Stock symbol
CTXR
Transactions as of
Oct 10, 2023
Transactions value $
$0
Form type
4
Date filed
10/12/2023, 04:15 PM
Previous filing
Nov 9, 2023
Next filing
Apr 5, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CTXR Common Stock 10.3M Oct 10, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CTXR Option to Purchase Common Stock Award $0 +550K $0.00 550K Oct 10, 2023 Common Stock 550K $0.70 Direct F10
holding CTXR Options to Purchase Common Stock 40K Oct 10, 2023 Common Stock 40K $3.45 Direct F1
holding CTXR Options to Purchase Common Stock 220K Oct 10, 2023 Common Stock 220K $6.75 Direct F2
holding CTXR Warrant to Purchase Common Stock 3.14M Oct 10, 2023 Common Stock 3.14M $1.15 Direct F3
holding CTXR Options to Purchase Common Stock 150K Oct 10, 2023 Common Stock 150K $1.62 Direct F4
holding CTXR Warrant to Purchase Common Stock 1.17M Oct 10, 2023 Common Stock 1.17M $1.42 Direct F3
holding CTXR Warrant to Purchase Common Stock 2.23M Oct 10, 2023 Common Stock 2.23M $0.77 Direct F3
holding CTXR Options to Purchase Common Stock 175K Oct 10, 2023 Common Stock 175K $0.67 Direct F5
holding CTXR Options to Purchase Common Stock 200K Oct 10, 2023 Common Stock 200K $1.01 Direct F6
holding CTXR Options to Purchase Common Stock 300K Oct 10, 2023 Common Stock 300K $2.00 Direct F7
holding CTXR Option to Purchase Common Stock 650K Oct 10, 2023 Common Stock 650K $2.04 Direct F8
holding CTXR Option to Purchase Common Stock 550K Oct 10, 2023 Common Stock 550K $1.25 Direct F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options vested in full on September 13, 2020.
F2 The options vested in full on September 12, 2017
F3 The warrant is fully vested and exercisable immediately.
F4 The options vested in full on September 4, 2021.
F5 The options vested in full on October 8, 2022.
F6 The options vested in full on October 6, 2023.
F7 The options were granted on July 22, 2021. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date.
F8 The options were granted on October 11, 2021. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date.
F9 The options were granted on October 4, 2022. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date.
F10 The options were granted on October 10, 2023. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date.